EUVIMEDEUVIMED entdecken
Crossref

A Fentanyl Hapten‐Displaying Lipid Nanoparticle Vaccine that Non‐Covalently Encapsulates a TLR7/8 Agonist and T‐Helper Epitope Induces Protective Anti‐Fentanyl Immunity

Zifu Zhong, Marie H Deventer iD, Yong Chen, Stijn Vanhee iD, Inés Lammens, Kim Deswarte iD, Yi Huang, Tingting Ye, Haixiu Wang, Lutz Nuhn, Marthe M Vandeputte, Mark Gontsarik und 7 weitere

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202419031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Zifu Zhong und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Ghent University, Belgium, Ottergemsesteenweg 460, Gent, 9000, Belgium. Hauptthemen laut MEDLINE: Fentanyl, Toll-Like Receptor 7, Toll-Like Receptor 8, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opioid use disorder ‐ particularly involving fentanyl ‐ has precipitated a public health crisis characterized by a significant increase in addiction and overdose‐related deaths. Fentanyl‐specific immunotherapy, which aims at inducing fentanyl‐specific antibodies capable of binding fentanyl molecules in the bloodstream, preventing their entry in the central nervous system, is therefore gaining momentum. Conventional opioid designs rely on the covalent conjugation of fentanyl analogues to immunogenic carrier proteins that hold the inherent capacity of mounting immunodominant responses. Here, we present an alternative fentanyl vaccine design that utilizes a non‐covalent assembly of lipid nanoparticles (LNPs) to deliver fentanyl haptens in conjunction with a CD4 + T‐helper peptide epitope and an imidazoquinoline TLR7/8 agonist. Our results demonstrate that a single intramuscular administration of the LNP‐based nanovaccine elicits fentanyl‐specific antibodies, significantly mitigating the effects of opioid overdose in preclinical mouse models. Furthermore, we analyzed the immunobiological behavior of the vaccine in vivo in mouse models, providing evidence that covalent attachment of a fentanyl hapten to a carrier proteins or peptide epitope is not necessary for inducing an effective immune response. However, co‐delivery ‐ specifically, the physical assembly of all immune cues into an LNP ‐ remains essential for inducing hapten‐specific immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylToll-Like Receptor 7Toll-Like Receptor 8NanoparticlesHaptensVaccinesAnimalsMiceNanovaccinesLiposomes

Stichwörter der Autor:innen

fentanyl vaccinehaptenimidazoquinolineslipid nanoparticlepeptide

Substanzen

FentanylToll-Like Receptor 7Toll-Like Receptor 8HaptensVaccinesLipid NanoparticlesNanovaccinesLiposomes

Autor:innen und Institutionen

  • Department of Pharmaceutics, Ghent University, Belgium, Ottergemsesteenweg 460, Gent, 9000, Belgium.
  • Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, 9000, Ghent, Belgium.
  • Department of Internal Medicine and Pediatrics, Ghent University, Technologiepark-Zwijnaarde 71, Gent, Ghent, 9052, Belgium.
  • Laboratory of immunoregulation and mucosal immunology, VIB Center for Inflammation Research, Technologiepark-Zwijnaarde 71, Ghent, 9052, Belgium Ghent, Belgium.
  • Department of Head and Skin, Ghent University, Gent, Belgium.
  • Institute of Functional Materials and Biofabrication, Department of Chemistry and Pharmacy, Julius-Maximilians-Universität Würzburg, Würzburg, 97070, Germany.

ORCID-Profile: Marie H Deventer, Stijn Vanhee, Kim Deswarte, Bruno G De Geest

Förderung

  • European Research Council

Zitieren

APA

Zhong, Z., Deventer, M. H., Chen, Y., Vanhee, S., Lammens, I., Deswarte, K., Huang, Y., Ye, T., Wang, H., Nuhn, L., Vandeputte, M. M., Gontsarik, M., Cui, X., Sanders, N. N., Lienenklaus, S., N Lambrecht, B., Baptista, A. P., Stove, C. P., & G De Geest, B. (2025). A Fentanyl Hapten‐Displaying Lipid Nanoparticle Vaccine that Non‐Covalently Encapsulates a TLR7/8 Agonist and T‐Helper Epitope Induces Protective Anti‐Fentanyl Immunity. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202419031

Vancouver

Zhong Z, Deventer MH, Chen Y, Vanhee S, Lammens I, Deswarte K, et al. A Fentanyl Hapten‐Displaying Lipid Nanoparticle Vaccine that Non‐Covalently Encapsulates a TLR7/8 Agonist and T‐Helper Epitope Induces Protective Anti‐Fentanyl Immunity. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202419031

BibTeX
@article{Zhong2025,
  author = {Zhong, Zifu and Deventer, Marie H and Chen, Yong and Vanhee, Stijn and Lammens, Inés and Deswarte, Kim and Huang, Yi and Ye, Tingting and Wang, Haixiu and Nuhn, Lutz and Vandeputte, Marthe M and Gontsarik, Mark and Cui, Xiaole and Sanders, Niek N and Lienenklaus, Stefan and N Lambrecht, Bart and Baptista, Antonio P and Stove, Christophe P and G De Geest, Bruno},
  title = {A Fentanyl Hapten‐Displaying Lipid Nanoparticle Vaccine that Non‐Covalently Encapsulates a TLR7/8 Agonist and T‐Helper Epitope Induces Protective Anti‐Fentanyl Immunity},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202419031}
}
Kostenlos starten →